CPHD: Summary for CEPHEID - Yahoo! Canada Finance - Share Prices, Charts, News and more

MORE ON CPHD

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

CEPHEID (NasdaqNM:CPHD) Delayed quote data

Last Trade:	14.99 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	14.99
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	16.63

Day's Range:	N/A - N/A
52wk Range:	4.93 - 16.47
Volume:	0
Avg Vol (3m):	413,033
Market Cap:	878.35M
P/E (ttm):	N/A
EPS (ttm):	-0.39
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add CPHD to Portfolio

Download Data

HEADLINES

•	4 Stocks Bouncing Back
	at Motley Fool (Wed, Feb 3)

•	New Star Analyst Rankings for CEPHEID
	StarMine (Sat, Jan 30)

•	UPDATE - Cepheid posts narrower quarterly loss
	at Reuters (Thu, Jan 28)

•	CEPHEID Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
	EDGAR Online (Thu, Jan 28)

•	Cepheid Reports Fourth Quarter and Full Year 2009 Results
	PRNewswire (Thu, Jan 28)

•	Q4 2009 Cepheid Earnings Release - After Market Close
	CCBN (Thu, Jan 28)

•	A Big Upgrade for Cepheid
	at Motley Fool (Tue, Jan 26)

•	2 Stocks Hitting Low Notes
	at Motley Fool (Mon, Jan 25)

•	Coverage initiated on Cepheid by Jefferies & Co
	Briefing.com (Thu, Jan 21)

•	20 'Babies with Bathwater' and 7 'Dogs with Fleas' Stocks for the Week
	at Seeking Alpha (Mon, Jan 18)

•	Cepheid Earnings Call scheduled for Thu, Jan 28
	CCBN (Thu, Jan 14)

More Headlines for CPHD...

ANALYST

EPS Est (next year) (Dec-10) :	-0.28
EPS Est (in 2 years) (Dec-11) :	0.09
Avg Rec (current)*:	2.3
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for genetic testing in the clinical molecular diagnostic, industrial, and biothreat markets.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Cepheid (CPHD)